FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Fuse Medical 510(k) for Knee System

FDA clears a Fuse Medical 510(k) for its Tibial Revision Knee System and the PS Plus Posterior Stabilized Tibial Insert.

Human Drugs

10 Observations on Fujifilm Diosynth FDA-483

FDA releases an FDA-483 with 10 observations from an inspection at the Fujifilm Diosynth Biotechnologies drug substance manufacturing facility.

Medical Devices

FDA Warns UK Face Mask Marketer

FDA issues a Warning Letter to Invisi Smart Technologies (United Kingdom) over its Invisi Smart Mask for sale in the U.S. without a cleared 510(k).

Human Drugs

Amneal Plans Parkinsons NDA for IPX-203

Amneal Pharmaceuticals says it will file an NDA for IPX-203 in mid-2022, after reporting positive topline results from a Phase 3 clinical trial that e...

Federal Register

eCTD Submisson Rejections Due to Validation Failures

Federal Register notice: FDA announces that beginning 3/1/2022 it will reject Electronic Common Technical Document submissions that fail validations 1...

Federal Register

Comments Sought on Environmental Impact Considerations

Federal Register notice: FDA seeks comments on an information collection extension entitled Environmental Impact Considerations (OMB Control Number 09...

Medical Devices

Baxter Spectrum Pump Urgent Correction

Baxter says it expects to deploy a software upgrade for its Spectrum IQ infusion pumps in the fourth quarter to address an issue experienced by some c...

Medical Devices

Labeling for AI/Machine Learning Devices Workshop

FDA announces a 10/14 virtual public workshop on improving transparency of artificial intelligence/machine learning-enabled medical devices by enhanci...

Human Drugs

Stealth Submits Elamipretide NDA Over FDA Concerns

Stealth BioTherapeutics says it has acceded to Barth syndrome patient community requests and submitted an NDA for elamipretide despite FDA concerns th...

Human Drugs

10 Accelerated Approval Reforms Evaluated

Researchers evaluate 10 possible reforms to the FDA accelerated approval pathway.